Skip to main content
. 2022 Apr;13(2):630–636. doi: 10.21037/jgo-22-279

Table 2. Efficacy of aTS and SOX treatment.

Efficacy aTS (n=33) SOX (n=37) P value
CR, n (%) 0 (0.0) 1 (2.7) 0.038
PR, n (%) 18 (54.5) 10 (27.0)
SD, n (%) 15 (45.5) 22 (59.5)
PD, n (%) 0 (0.0) 4 (10.8)
ORR (%) 54.5 29.7

aTS, albumin-bound paclitaxel combined with S-1; SOX, standard S-1 and oxaliplatin; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; ORR, objective response rate.